key: cord-1054769-byva1yaq
authors: Qiu, Shizheng; Hu, Yang; Cheng, Liang
title: A genome-wide cross-trait analysis highlights the shared genetic structure between COVID-19 and Alzheimer's disease
date: 2021-08-27
journal: J Infect
DOI: 10.1016/j.jinf.2021.08.038
sha: c95cf3dbf75ab058b676d6f753697985779e86ae
doc_id: 1054769
cord_uid: byva1yaq

nan

who reported the higher mortality of COVID-19 patients with dementia compared with COVID-19 patients without dementia (effect estimate = 1.84, 95% CI: 1.57-2.16) (1) .

Meanwhile, patients recovering from COVID-19 had a more severe burden of cognitive impairment, suggesting the potential risk of Alzheimer's disease (2) . Although growing evidences indicate the potential genetic overlap between Alzheimer's disease and COVID-19, the genetic association degree and the shared genetic structure region between the two diseases remain unknown (3) . In this study, we aim to clarify the following three questions: (Ⅰ) Does the genetic association exist between COVID-19 and Alzheimer's disease? (Ⅱ) Where is the shared genetic region between COVID-19 and Alzheimer's disease? (Ⅲ) Is there a causal relationship between COVID-19 and Alzheimer's disease?

In order to answer these questions, we obtained two large-scale genome-wide association studies (GWAS) summary statistics of Alzheimer's disease and COVID-19, respectively from International Genomics of Alzheimer's Project (IGAP) and COVID-19 Host Genetics Initiative (4, 5) . All the participants were of European descent. In stage 1, we evaluated genetic correlation between Alzheimer's disease and COVID-19 using linkage disequilibrium score (LDSC) regression analysis (6) . From an overall point of view, the genetic association seemed to have only suggestive significance (r g = 0.1048, P = 0.0782). In stage 2, We divided the gene components into 1703 LD-independent segments and calculated local genetic correlation of each segment respectively using HESS (heritability estimation from summary statistics). Chr19:44744108-46102697, containing several known Alzheimer's disease susceptibility loci, was the shared genetic region of Alzheimer's disease and COVID-19 (P = 4.38E-04). In chr19:44744108-46102697, APOE and APOC1 have been proven to be enriched in certain immune cells or tissues of COVID-19 patients and mediate the infection of SARS-CoV2 in neurons and astrocytes (7, 8) . In stage 3, we performed a bidirectional two-sample Mendelian randomization (MR) analysis to reveal the causality between Alzheimer's disease and COVID-19 (9) . When Alzheimer's disease was used as exposure and COVID-19 as outcome, 18 genetic variants were used as instrumental variables to carry out MR analysis. Inverse variance weighted (IVW) method showed a higher risk of COVID-19 for Alzheimer's disease patients (OR = 1.06, 95% CI: 1.00-1.12, P = 0.042) ( Table 1) .

However, reverse MR found no evidence that COVID-19 led to Alzheimer's disease (P = 0.202).

In conclusion, we supported the potential genetic association between Alzheimer's disease and COVID-19, which was mainly reflected in chr19:44744108-46102697 region.

Alzheimer's disease were more susceptible to COVID-19. Although Alzheimer's disease might increase the risk of COVID-19, the causality was not clear enough ( Table 1) . We recommend that our views should be further validated in future clinical and observational studies. 

The association of dementia with COVID-19 mortality: Evidence based on adjusted effect estimates

High-dimensional characterization of post-acute sequelae of COVID-19

Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease

Mapping the human genetic architecture of COVID-19

Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing

An atlas of genetic correlations across human diseases and traits

Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19. Cells

ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response

The MR-Base platform supports systematic causal inference across the human phenome. Elife

We thank International Genomics of Alzheimer's Project (IGAP) and COVID-19 Host Genetics Initiative for providing GWAS summary statistics.

All the authors declare no conflicts of interest